FDA Adverse Event Other Summary report: N

ESSURE

MDR report key: 2851108 · Received November 16, 2012

Report

Report Number
2951250-2012-00049
Event Type
Other
Date Received
November 16, 2012
Date of Event
October 18, 2012
Report Date
January 19, 2017
Manufacturer
BAYER PHARMA AG
Product Code
HHS
PMA / PMN Number
P020014
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

PATIENT REPORTED TO MANUFACTURER THAT FOLLOWING HSG TEST, (B)(6) PHYSICIAN TOLD HER THAT SHE WAS NOW STERILE AND COULD RELY ON DEVICES. SHE SUBSEQUENTLY HAD AN ECTOPIC PREGNANCY FOLLOWED BY AN INTRAUTERINE PREGNANCY. DATE OF AND TREATMENT FOR ECTOPIC PREGNANCY ARE UNKNOWN. SECOND PREGNANCY OCCURED APPROXIMATELY IN (B)(6) 2011. (B)(6). MANUFACTURER HAS MADE NUMEROUS ATTEMPTS TO CONTACT PATIENT, BUT HAS BEEN UNABLE TO OBTAIN FURTHER INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ESSURE INSERT, TUBAL OCCLUSION HHS BAYER PHARMA AG ESS305 UNK

Patients

Seq Age Sex Outcome Treatment
1 31 YR Required Intervention